[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 2 of about 2
1. Kumagai D, Yamate J, Tajima T, Tsukamoto Y, Yasui H, Kuwamura M, Kotani T, Sakuma S: Distribution of cells labelled by a monoclonal antibody (A3) against a cloned cell line derived from a rat malignant fibrous histiocytoma. J Comp Pathol; 2000 Aug-Oct;123(2-3):77-87
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A3 reacted specifically with MT-8 cells, with another rat MFH-derived cell line (MT-9) and with their induced tumours in syngeneic rats, but not with other rat tumours such as fibrosarcoma, histiocytic sarcoma, malignant meningioma, uterine leiomyosarcoma, endometrial stromal sarcoma, mononuclear cell leukaemia and malignant schwannoma.
  • [MeSH-major] Antibodies, Monoclonal / pharmacokinetics. Histiocytoma, Benign Fibrous / metabolism
  • [MeSH-minor] Animals. Aorta / chemistry. Aorta / embryology. Carbon Tetrachloride / adverse effects. Cisplatin / adverse effects. Drug-Induced Liver Injury. Immunohistochemistry. Kidney Diseases / chemically induced. Kidney Diseases / metabolism. Kidney Diseases / pathology. Liver / chemistry. Liver / embryology. Liver Diseases / metabolism. Liver Diseases / pathology. Lung / chemistry. Lung / embryology. Lung / ultrastructure. Mice. Mice, Inbred BALB C. Microscopy, Immunoelectron. Rats. Rats, Inbred F344. Spinal Cord / chemistry. Spinal Cord / embryology. Tumor Cells, Cultured / immunology. Tumor Cells, Cultured / metabolism. Tumor Cells, Cultured / ultrastructure

  • Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .
  • Hazardous Substances Data Bank. CARBON TETRACHLORIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2000 Harcourt Publishers Ltd.
  • (PMID = 11032659.001).
  • [ISSN] 0021-9975
  • [Journal-full-title] Journal of comparative pathology
  • [ISO-abbreviation] J. Comp. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] ENGLAND
  • [Chemical-registry-number] 0 / Antibodies, Monoclonal; CL2T97X0V0 / Carbon Tetrachloride; Q20Q21Q62J / Cisplatin
  •  go-up   go-down


Advertisement
2. Goutagny S, Kalamarides M: Meningiomas and neurofibromatosis. J Neurooncol; 2010 Sep;99(3):341-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Neurofibromatosis type 2 (NF2) is a rare genetic disorder predisposing to multiple benign tumors of the nervous system.
  • Patients harboring seemingly isolated multiple meningiomas should be investigated to diagnose NF2 by careful familial history collection, detailed clinical examination (skin lesions and slit lamp examination of the lens), audiovestibular testing, and fine cranio-spinal Magnetic Resonance Imaging.
  • Neurofibromatosis type 1 is not associated with an increased risk of meningioma.
  • Thus, knowledge of tumor behavior is essential in slow growing tumors like meningiomas, to balance the risk of treatment against the natural history of the disease, and to evaluate the efficiency of alternative therapeutics (radiation therapy or new drugs).
  • [MeSH-major] Meningeal Neoplasms / diagnosis. Meningioma / diagnosis. Neurofibromatoses / diagnosis

  • Genetic Alliance. consumer health - Neurofibromatosis.
  • MedlinePlus Health Information. consumer health - Neurofibromatosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Q J Med. 1992 Aug;84(304):603-18 [1484939.001]
  • [Cites] Clin Cancer Res. 2009 Aug 15;15(16):5032-5039 [19671848.001]
  • [Cites] Neurosurgery. 1996 May;38(5):880-5; discussion 885-6 [8727812.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2009 Jan 1;73(1):208-13 [18687535.001]
  • [Cites] Neuropediatrics. 2005 Feb;36(1):21-34 [15776319.001]
  • [Cites] J Neurosurg. 1997 Oct;87(4):610-4 [9322850.001]
  • [Cites] Brain Pathol. 2008 Jan;18(1):62-70 [17924978.001]
  • [Cites] Neurology. 1993 Oct;43(10):2096-8 [8413972.001]
  • [Cites] J Med Genet. 2003 Feb;40(2):109-14 [12566519.001]
  • [Cites] J Med Genet. 2002 May;39(5):315-22 [12011146.001]
  • [Cites] Science. 2008 Sep 26;321(5897):1807-12 [18772396.001]
  • [Cites] J Pathol. 2001 Jul;194(3):367-72 [11439370.001]
  • [Cites] Neurogenetics. 2010 Feb;11(1):73-80 [19582488.001]
  • [Cites] BMC Med Genomics. 2009 Jul 09;2:42 [19589153.001]
  • [Cites] Genes Dev. 2002 May 1;16(9):1060-5 [12000789.001]
  • [Cites] Otol Neurotol. 2005 Jul;26(4):733-40 [16015177.001]
  • [Cites] J Neuropathol Exp Neurol. 2001 Oct;60(10):994-1003 [11589430.001]
  • [Cites] Brain. 1999 Mar;122 ( Pt 3):473-81 [10094256.001]
  • [Cites] J Neurosurg. 2004 Feb;100(2 Suppl Pediatrics):179-82 [14758946.001]
  • [Cites] Acta Neurochir (Wien). 1995;137(3-4):174-81 [8789658.001]
  • [Cites] Am J Pathol. 1995 Apr;146(4):827-32 [7717450.001]
  • [Cites] Am J Hum Genet. 2002 Oct;71(4):715-23 [12235555.001]
  • [Cites] J Med Genet. 2005 Jan;42(1):45-8 [15635074.001]
  • [Cites] Arch Ophthalmol. 2007 Mar;125(3):389-94 [17353411.001]
  • [Cites] Neurosurgery. 2007 Mar;60(3):460-8; discussion 468-70 [17327790.001]
  • [Cites] Am J Med Genet A. 2010 Feb;152A(2):327-32 [20082463.001]
  • [Cites] J Med Genet. 2006 Apr;43(4):289-94 [16155191.001]
  • [Cites] Rev Neurol (Paris). 2005 Mar;161(3):275-83 [15800448.001]
  • [Cites] J Med Genet. 2010 Aug;47(8):567-8 [20472658.001]
  • [Cites] J Neuropathol Exp Neurol. 2000 Jun;59(6):504-12 [10850863.001]
  • [Cites] J Neurosurg. 2009 Sep;111(3):458-63 [19199473.001]
  • [Cites] J Neurosurg. 2005 Dec;103(6 Suppl):489-95 [16383246.001]
  • [Cites] Clin Genet. 2007 Apr;71(4):354-8 [17470137.001]
  • [Cites] Am J Ophthalmol. 2006 Jun;141(6):1068-1077 [16765675.001]
  • [Cites] J Neurosurg. 1998 Mar;88(3):562-9 [9488313.001]
  • [Cites] Am J Hum Genet. 2007 Apr;80(4):805-10 [17357086.001]
  • [Cites] Arch Dis Child. 1999 Dec;81(6):496-9 [10569966.001]
  • [Cites] Neurology. 2005 Jun 14;64(11):1838-45 [15955931.001]
  • [Cites] Neurology. 1996 Apr;46(4):1072-9 [8780094.001]
  • [Cites] Am J Hum Genet. 1998 Sep;63(3):727-36 [9718334.001]
  • [Cites] N Engl J Med. 2009 Jul 23;361(4):358-67 [19587327.001]
  • [Cites] J Neurosurg. 1995 Oct;83(4):705-9 [7674021.001]
  • [Cites] Brain Pathol. 2005 Jan;15(1):55-65 [15779237.001]
  • [Cites] Neurology. 2000 Jan 11;54(1):71-6 [10636128.001]
  • [Cites] J Med Genet. 1999 Mar;36(3):197-203 [10204844.001]
  • [Cites] J Neurosurg. 2003 Sep;99(3):480-3 [12959433.001]
  • [Cites] Br J Ophthalmol. 1992 May;76(5):310-2 [1390517.001]
  • [Cites] J Med Genet. 2003 Jun;40(6):459-63 [12807969.001]
  • [Cites] Clin Genet. 2008 Oct;74(4):358-66 [18647326.001]
  • [Cites] Am J Med Genet. 1994 Oct 1;52(4):450-61 [7747758.001]
  • [Cites] J Neurosurg. 1994 Mar;80(3):447-53 [8113857.001]
  • (PMID = 20714782.001).
  • [ISSN] 1573-7373
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  •  go-up   go-down






Advertisement